Monoclonal Antibodies

Immune-based therapies are being studied extensively in a variety of immunological conditions due to their high precision and sensitivity. Monoclonal antibody (mAb) technology is a major advancement in the treatment of several infectious diseases, malignancies, and immunological disorders. This book...

Full description

Saved in:
Bibliographic Details
Format: Online
Language:English
Published: IntechOpen 2023
Subjects:
Online Access:ONIX_20231201_9781839683701_2244
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869523240835088384
collection Directory of Open Access Books
description Immune-based therapies are being studied extensively in a variety of immunological conditions due to their high precision and sensitivity. Monoclonal antibody (mAb) technology is a major advancement in the treatment of several infectious diseases, malignancies, and immunological disorders. This book provides comprehensive information about technologies, characterization, and application of mAbs in the clinic and laboratory.
format Online
id doab-20.500.12854ir-131133
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher IntechOpen
publisherStr IntechOpen
record_format ojs
spelling doab-20.500.12854ir-1311332024-03-31T22:43:51Z Monoclonal Antibodies Rezaei, Nima monoclonal antibody, immunotherapy, molecular docking, biosimilar, nk cells, daratumumab thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCM Immunology Immune-based therapies are being studied extensively in a variety of immunological conditions due to their high precision and sensitivity. Monoclonal antibody (mAb) technology is a major advancement in the treatment of several infectious diseases, malignancies, and immunological disorders. This book provides comprehensive information about technologies, characterization, and application of mAbs in the clinic and laboratory. 2023-12-01T18:54:42Z 2023-12-01T18:54:42Z 2021 book ONIX_20231201_9781839683701_2244 9781839683701 9781839683695 9781839683718 https://directory.doabooks.org/handle/20.500.12854/131133 eng image/jpeg n/a https://www.intechopen.com/books/8043 https://mts.intechopen.com/storage/books/8043/authors_book/authors_book.pdf IntechOpen IntechOpen 10.5772/intechopen.77874 10.5772/intechopen.77874 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781839683701 9781839683695 9781839683718 IntechOpen 170 open access
spellingShingle monoclonal antibody, immunotherapy, molecular docking, biosimilar, nk cells, daratumumab
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCM Immunology
Monoclonal Antibodies
title Monoclonal Antibodies
title_full Monoclonal Antibodies
title_fullStr Monoclonal Antibodies
title_full_unstemmed Monoclonal Antibodies
title_short Monoclonal Antibodies
title_sort monoclonal antibodies
topic monoclonal antibody, immunotherapy, molecular docking, biosimilar, nk cells, daratumumab
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCM Immunology
topic_facet monoclonal antibody, immunotherapy, molecular docking, biosimilar, nk cells, daratumumab
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCM Immunology
url ONIX_20231201_9781839683701_2244